246 Results

People

  1. Bajorin
    Bajorin
  2. Oettgen
    Oettgen
  3. Wong
    Wong
  4. Cheung
    Cheung
  5. Giralt
    Giralt
  6. Kelsen
    Kelsen
  7. Kemeny
    Kemeny
  8. Horwitz
    Horwitz
  9. O'Reilly
    O'Reilly
  10. Perales
    Perales

Groups

  1. Department of Medicine (137)
  2. Solid Tumor Oncology Division (69)
  3. Hematologic Malignancies, Division of (66)
  4. Center for Hematologic Malignancies (60)
  5. Surgery (29)
  6. Survivorship Research (29)
  7. GSK Faculty (26)
  8. Pediatrics, Department of (22)
  9. Adult Leukemia (20)
  10. Division of Subspecialty Medicine (19)
  1. "hypotension"
Formats
  1. Journal Article (226)
  2. Review (10)
  3. Conference Paper (3)
  4. Guidelines (2)
  5. Research Letter (2)
  6. Book Section (1)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Department of Medicine (137)
  2. Solid Tumor Oncology Division (69)
  3. Hematologic Malignancies, Division of (66)
  4. Center for Hematologic Malignancies (60)
  5. Surgery (29)
  6. Survivorship Research (29)

More Groups

People
  1. Dean Bajorin (11)
  2. Nancy Kemeny (9)
  3. George Wong (7)
  4. Herbert Oettgen (7)
  5. Paul Chapman (7)
  6. David Kelsen (6)

More People

Years
  1. 2025 (11)
  2. 2024 (12)
  3. 2023 (8)
  4. 2022 (8)
  5. 2021 (4)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Cancer (13)
  3. Blood (12)
  4. Lancet Oncology (12)
  5. Clinical Cancer Research (9)
  6. Gynecologic Oncology (6)

More Publications

Publishers
  1. Elsevier Inc. (37)
  2. Elsevier Science, Inc. (19)
  3. Springer (18)
  4. Wiley Blackwell (18)
  5. American Society of Clinical Oncology (16)
  6. American Society of Hematology (14)

More Publishers

Results (246)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Feasibility of combining the phosphatidylinositol 3-kinase inhibitor copanlisib with rituximab-based immunochemotherapy in patients with relapsed indolent B-cell lymphoma
    Journal Article

    Matasar, M. J.; Dreyling, M.; Leppä, S.; Santoro, A.; Pedersen, M.; Buvaylo, V.; Fletcher, M.; Childs, B. H.; Zinzani, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • New advances in tissue metabolomics: A review
    Review

    Saoi, M.; Britz-Mckibbin, P.
    Metabolites (2021)

    Fulltext@MSK | Save
  • CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: An open-label, multicentre, phase 1b study
    Journal Article

    O'Hara, M. H.; O'Reilly, E. M.; Varadhachary, G.; Wolff, R. A.; Wainberg, Z. A.; Ko, A. H.; Fisher, G.; Rahma, O.; Lyman, J. P.; Cabanski, C. R.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Huh, W. K.; Brady, W. E.; Fracasso, P. M.; Dizon, D. S.; Powell, M. A.; Monk, B. J.; Leath, C. A. 3rd; Landrum, L. M.; Tanner, E. J.; Crane, E. K.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • The impact of fluid optimisation before induction of anaesthesia on hypotension after induction: A reply
    Correspondence

    Arslan-Carlon, V.
    Anaesthesia (2020)

    Fulltext@MSK | Save
  • Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
    Research Letter

    Sawas, A.; Ma, H.; Shustov, A.; Hsu, P.; Bhat, G.; Acosta, M.; Horwitz, S.; O’Connor, O. A.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: A single-centre, double-blind, parallel-group, randomised trial
    Journal Article

    Hui, D.; De La Rosa, A.; Wilson, A.; Nguyen, T.; Wu, J.; Delgado-Guay, M.; Azhar, A.; Arthur, J.; Epner, D.; Haider, A.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Management of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah’s Witness
    Journal Article

    Rubinstein, M. M.; Goss, C.; Avecilla, S. T.; Dubé, G. P.; Riely, G. J.; Mones, J. V.
    Clinical Case Reports (2020)

    Fulltext@MSK | Save
  • Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?
    Research Letter

    Nawar, T.; Morjaria, S.; Kaltsas, A.; Patel, D.; Perez-Johnston, R.; Daniyan, A. F.; Mailankody, S.; Parameswaran, R.
    American Journal of Hematology (2020)

    Fulltext@MSK | Save
  • DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
    Journal Article

    Wudhikarn, K.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; Shah, G. L.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save